✦ LIBER ✦

Oral apremilast in the treatment of active psoriatic arthritis: Results of a multicenter, randomized, double-blind, placebo-controlled study

✍ Scribed by Georg Schett; Jurgen Wollenhaupt; Kim Papp; Rik Joos; Jude F. Rodrigues; Adele R. Vessey; ChiaChi Hu; Randall Stevens; Kurt L. de Vlam

Book ID: 115550534
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 357 KB
Volume: 64
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.34627

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alefacept in combination with methotrexa

Alefacept in combination with methotrexate for the treatment of psoriatic arthritis: Results of a randomized, double-blind, placebo-controlled study

✍ Philip J. Mease; Dafna D. Gladman; Edward C. Keystone 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 2 views

## Abstract ## Objective To evaluate the efficacy and safety of alefacept in combination with methotrexate (MTX) for the treatment of psoriatic arthritis (PsA). ## Methods Patients were eligible for this randomized, double‐blind, placebo‐controlled trial if they were ages 18–70 years and had act

Sulfasalazine in the treatment of juveni

Sulfasalazine in the treatment of juvenile chronic arthritis: A randomized, double-blind, placebo-controlled, multicenter study

✍ Marion A. J. van Rossum; Theo J. W. Fiselier; Marcel J. A. M. Franssen; Aeilko H 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 987 KB

Objective. To assess the efficacy, tolerability, and safety of sulfasalazine (SSZ) in the treatment ofjuvenile chronic arthritis (JCA). Methods. We conducted a 24-week randomized, placebo-controlled, double-blind, multicenter study of patients with active JCA of both oligoarticular and polyarticula

Abatacept in the treatment of patients w

Abatacept in the treatment of patients with psoriatic arthritis: Results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial

✍ Philip Mease; Mark C. Genovese; Geoffrey Gladstein; Alan J. Kivitz; Christopher 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 3 views

Adalimumab for the treatment of patients

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double-blind, randomized, placebo-controlled trial

✍ Philip J. Mease; Dafna D. Gladman; Christopher T. Ritchlin; Eric M. Ruderman; Se 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Safety of efalizumab in patients with ps

Safety of efalizumab in patients with psoriatic arthritis: results of a phase II, randomized, double-blind, placebo-controlled study

✍ Kim Papp; Phil Mease; Marvin Garovoy; David Zhang 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Alefacept in combination with methotrexa

Alefacept in combination with methotrexate for treatment of active psoriatic arthritis: rationale and design of a randomized, double-blind, placebo-controlled study

✍ Dafna Gladman; Edward Keystone; Alice Gottlieb 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 58 KB